BIO, PhRMA Medicare Payment Rule Comments Seek “Interim” Increase
Executive Summary
Industry trade associations are proposing that Medicare reimburse non-pass-through drugs at no less than 88% of AWP in 2004 while CMS reworks its payment setting methodology